Drug Testing

LifeSign MI

The shooting ache in the chest region sets of waves of panic in patients who fear the worst, yet studies have shown that approximately 50% of patients admitted to the ER with chest pains have no significant heart disease present.

The availability of a cardiac panel in a rapid test format that allows healthcare professionals to improve patient outcomes by differentiating between a true emergency and a bad case of indigestion is now available from LifeSign.

The LifeSign MI family of cardiac tests allows for rapid qualitative detection of cardiac markers in 15 minutes with an easy to read immunoassay. Performing these tests at the point of care

• reduces potential ER overcrowding
• improves patient care
• reduces unnecessary testing and admissions

The LifeSign MI tests are Troponin I, the simultaneous detection of Myoglobin/Troponin I, and the simultaneous detection of Myoglobin/CK-MB/Troponin I.

These cardiac markers are enzymes or proteins that are released into the bloodstream in response to ischemia and detect injury to the myocardium. Enzymes are released at various stages of MI:

Myoglobin Appears in the bloodstream in abnormal levels as early as 2-3 hours after onset of chest pain.
CK-MB Not normally elevated until 4 to 6 hours after the onset of an MI
Troponin I Appears in the bloodstream 4 to 6 hours after muscle damage

With its easy procedure and fast turnaround
time, the LifeSign MI is perfect for:

Emergency Rooms
Main Hospital Laboratories who are short-staffed
Urgent Care Facilities
Critical Care Clinics
Occupational Safety
Oncology (for heart damage resulting in high dosages of chemotherapy

	Procedure
	Dispense three (3) drops (120ul) of blood, serum, or plasma into the test well Read Results in 15 minutes A line next to the cardiac marker and a line on the control line indicates the marker concentration is above the cutoff for an MI.